Risk factors and antimicrobial susceptibility in ventilator associated pneumonia: A brief report

Tehran University Medical Journal

Volumn 70, Issue 9, 2012, Pages 577-582

  Talebi Taher, Mahshid ^a   Latifnia, Maryam ^a   Javad Moosavai, Seied Ali ^a   Adabi, Maryam ^b   Lari, Abdolaziz Rastgar ^a   Abdizadeh, Mojtaba Fatahi ^b   Babazadeh, Shahin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AhvazUniversity of Medical Sciences ^*  (Iran)

Author keywords

Acinetobacter species; Drug susceptibility; Ventilator associated pneumonia (VAP)

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; CROSS-SECTIONAL STUDY; DISK DIFFUSION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; RISK FACTOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84971654274     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42 (5):692-9.
2. Struelens MJ, Carlier E, Maes N, Serruys E, Quint WG, van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect 1993;25(1):15-32.
3. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006;55(Pt 12):1619-29.
4. Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012;73(4):354-60.
5. Khalili H, Soltani R, Safhami S, Dashti-Khavidaki S, Alijani B. Antimicrobial resistance pattern of gram-negative bacteria of nosocomial origin at a teaching hospital in the Islamic Republic of Iran. East Mediterr Health J 2012;18(2):172-7.
6. Hashemizadeh Z, Bazargani A, Emami A, Rahimi MJ. Acinetobacter antibiotic resistance and frequency of ESBL-producing strains in ICU patients of Namazi Hospital (2008-2009). JQUMS 2010;14(2):47-53. [Persian]
7. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999; 115(5):1378-82.
8. Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005;31(5):649-55.
9. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122(1):262-8.
10. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003;47(5):1681-8.
11. Basustaoglu AC, Kisa O, Sacilik SC, Ozyurt M, Yildiran ST. Epidemiological characterization of hospital-acquired Acinetobacter baumannii isolates from a 1500-bed teaching hospital by phenotypic and genotypic methods. J Hosp Infect 2001;47(3):246-7.
12. Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillinsulbactam treatment. J Hosp Infect 2003;54(1):32-8.
13. Hadadi A, Rasoulinejad M, Maleki Z, Mojtabazadeh M, Younesian M, Ahmadi SA, et al. Antimicrobial resistance patterns among Gram-negative bacilli isolated from patients with nosocomial infections: Disk diffusion versus E-test. Tehran Univ Med J (TUMJ);65(4):1-10.
14. Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28(5):1008-11.
15. Swenson JM, Killgore GE, Tenover FC. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilu tion and disk diffusion methods. J Clin Microbiol 2004;42(11):5102-8.
16. Shete VB, Ghadage DP, Muley VA, Bhore AV. Multi-drug resistant Acinetobacter ventilator-associated pneumonia. Lung India 2010;27 (4):217-20.
17. Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48(1):224-8. Erratum in: Antimicrob Agents Chemother 2004;48(3): 1070.